SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-124783
Filing Date
2021-04-21
Accepted
2021-04-21 16:31:03
Documents
14
Period of Report
2021-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d40591d8k.htm   iXBRL 8-K 30461
2 EX-99.1 d40591dex991.htm EX-99.1 15284
6 GRAPHIC g40591g0421110630672.jpg GRAPHIC 2440
  Complete submission text file 0001193125-21-124783.txt   180794

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210415.xsd EX-101.SCH 3091
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210415_lab.xml EX-101.LAB 18133
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210415_pre.xml EX-101.PRE 11420
7 EXTRACTED XBRL INSTANCE DOCUMENT d40591d8k_htm.xml XML 3428
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 21841881
SIC: 2834 Pharmaceutical Preparations